-
Ginger-Derived Exosome-Like Nanoparticles Loaded With Indocyanine Green Enhances Phototherapy Efficacy for Breast Cancer
30 Jan 2025 07:20 GMT
… mediated breast tumor therapy effect by directly inhibiting breast tumor malignant … significantly facilitated photo-mediated breast tumor therapy. Furthermore, the … agreed on the journal to which the … associated with basal-like breast cancer cell invasion. J …
-
AI Can Predict Breast Cancer Risk Years Before Diagnosis, Study Finds
30 Jan 2025 04:14 GMT
… elevated risk of developing breast cancer several years before … higher risk of developing breast cancer, and even identify which … is published in the Journal of the American Medical … collection of prestigious medical journals.
The Norwegian detection programme …
-
Sermonix Announces Clinical Breast Cancer Publication of Article Examining Effects of Lasofoxifene Versus Fulvestrant on Urogenital Symptoms in Patients with ESR1-Mutated ER+/HER2- Metastatic Breast Cancer
29 Jan 2025 15:19 GMT
… treat metastatic breast cancers (mBC), … Breast Cancer from the ELAINE-1 Study,” in the peer-reviewed journal Clinical Breast Cancer … breast cancer. We are very pleased that Clinical Breast Cancer, a prestigious peer-reviewed journal … ER+ breast cancer.
About …
-
Roche announces positive results from phase III INAVO120 study of Itovebi in combo with palbociclib & fulvestrant in a certain type of HR─positive advanced breast cancer
29 Jan 2025 05:39 GMT
… in the New England Journal of Medicine, are … locally advanced or metastatic breast cancer whose disease progressed … advanced or metastatic breast cancer in various combinations: … -negative breast cancer (INAVO123; NCT06790693).
HR-positive breast cancer is the …
-
US FDA approves AstraZeneca & Daiichi Sankyo’s Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies
29 Jan 2025 04:34 GMT
… in The New England Journal of Medicine.
Aditya … HR-positive metastatic breast cancer and following progression, … new breast cancer settings.
In HR-positive breast cancer, AstraZeneca … -negative breast cancer, an aggressive form of breast cancer, AstraZeneca …
-
Asymptomatic brain metastasis in stage 4 breast cancer requires reevaluation of screening guidelines
29 Jan 2025 02:36 GMT
… in triple-negative breast cancer
15% in HER2-positive breast cancer
10% in … hormone receptor-positive/HER2-negative breast cancer
… supported by the Florida Breast Cancer Foundation.
Source:
Journal reference:
Ahmed, K. …
-
New analysis asserts survival benefit for Roche breast cancer therapy
29 Jan 2025 02:30 GMT
… HR-positive, HER2-negative breast cancer.
Updated Phase III analysis … locally advanced or metastatic breast cancer.
Itovebi is an oral … for patients with this breast cancer indication”
Prior primary analysis … in the New England Journal of Medicine.
Full results …
-
Moffitt Research Calls for Regular Brain MRI Screening in Asymptomatic Late-Stage Breast Cancer Patients
29 Jan 2025 00:23 GMT
… cancer monitoringHER2-positive breast cancer researchhormone receptor-positive breast cancer findingsimportance of … asymptomatic breast cancer patientsNeuro-Oncology journal studyreevaluating cancer screening guidelinestriple-negative breast cancer …
-
Enhertu Approved in the US for Metastatic Breast Cancer
28 Jan 2025 23:27 GMT
… in The New England Journal of Medicine.
Aditya Bardia … of HR-positive metastatic breast cancer and following progression, … or HER2-ultralow metastatic breast cancer following endocrine therapy.”
… with HER2-expressing metastatic breast cancer. The approval also …
-
FDA Approves Trastuzumab Deruxtecan for HER2-Low/Ultralow Breast Cancer
28 Jan 2025 23:22 GMT
… of HR-positive metastatic breast cancer and following progression, … or HER2-ultralow metastatic breast cancer following endocrine therapy.” … Klemow to The American Journal of Managed Care® ( … with HER2-expressing metastatic breast cancer,” said Dave Fredrickson …
About
© 1995-2025